Margaret Mooney - Concepedia

Author

Margaret Mooney

Also Known As

M. M. Mooney, M. Mooney, M.M. Mooney, Margaret M. Mooney, Margaret M Mooney, Margaret M. Mooney, Margaret Mooney, Mooney, Margaret M, O'Neil, Bert, Schilsky, Richard L.

128

Publications

31.9K

Citations

H-Index

132

Concepts

All Affiliations

National Cancer Institute Mayo Clinic in Arizona The University of Texas MD Anderson Cancer Center Dana-Farber Cancer Institute National Institutes of Health

About

Margaret Mooney is an author at National Cancer Institute specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	17	29.5K
2	Health Sciences	9	9	29.3K
3	Engineering	3	3	59
4	Education	2	2	26
5	Business	1	1	19

Margaret Mooney

Publications

30.6K

Citations

H-Index

Page 1

	Year	Citations
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) E. Eisenhauer, P. Therasse, Jan Bogaerts, European Journal of Cancer Surgical OncologyRecist GuidelineMedicineCancer ManagementSolid Tumours	2008	28.6K
Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting Melanie B. Thomas, Deborah Jaffe, Michael M. Choti, Journal of Clinical Oncology GastroenterologyPathologyHepatic DisordersOncologyGastrointestinal Oncology	2010	393
Phase II Multicenter Trial of Bevacizumab Plus Fluorouracil and Leucovorin in Patients With Advanced Refractory Colorectal Cancer: An NCI Treatment Referral Center Trial TRC-0301 Helen X. Chen, Margaret Mooney, Matthew Boron, Journal of Clinical Oncology	2006	186
Insurance Status and the Use of Guideline Therapy in the Treatment of Selected Cancers Linda C. Harlan, Amanda Greene, Limin X. Clegg, Journal of Clinical Oncology	2005	157
Recommendations for the assessment of progression in randomised cancer treatment trials Janet Dancey, Lori E. Dodd, Robert Ford, European Journal of Cancer MedicineCancer ManagementClinical TrialsCancer TreatmentOncology	2008	109
Patterns of Care for Adjuvant Therapy in a Random Population-Based Sample of Patients Diagnosed with Colorectal Cancer Deirdre Cronin, Linda C. Harlan, Arnold L. Potosky, The American Journal of Gastroenterology	2006	96
Primary Extremity Sarcoma: What Is the Appropriate Follow-Up? Brian P. Whooley, John F. Gibbs, Margaret Mooney, Annals of Surgical Oncology Surgical OncologyMedicineLower Limb TraumaPrimary Extremity SarcomaSurgery	2000	94
Tazemetostat for tumors harboring SMARCB1/SMARCA4 or EZH2 alterations: results from NCI-COG pediatric MATCH APEC1621C P. Mickey Williams, Sinchita Roy‐Chowdhuri, David R. Patton, JNCI Journal of the National Cancer Institute	2023	78
Mindful Climate Action: Health and Environmental Co-Benefits from Mindfulness-Based Behavioral Training Bruce Barrett, Maggie Grabow, Cathy Middlecamp, Sustainability Health PsychologyMental HealthMindfulness InterventionSocial SciencesPsychology	2016	71
Steps and Time to Process Clinical Trials at the Cancer Therapy Evaluation Program David M. Dilts, Alan B. Sandler, Steven K. Cheng, Journal of Clinical Oncology	2009	68

Page 1